ArticlePediatric blood & cancer2013

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916).

Jodi A Muscal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.